Aim Bulletin

4basebio losses widen as it progresses commercial development

By Josh White

Date: Friday 27 Sep 2024

(Sharecast News) - 4basebio, a biotechnology company specialising in synthetic DNA products and nucleic acid delivery platforms, reported revenue of over £0.3m for the six months ended 30 June on Friday.
The AIM-traded company said its order book stood at more than £0.6m at the end of the first half, reflecting...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page